Page last updated: 2024-12-05

dicrotophos

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

dicrotophos: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5371560
CHEMBL ID1876467
CHEBI ID38658
SCHEMBL ID26457
SCHEMBL ID3734382
MeSH IDM0040941

Synonyms (103)

Synonym
nsc-370784
nsc370784
(e)-phosphoric acid, 3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl ester
(1e)-3-(dimethylamino)-1-methyl-3-oxoprop-1-en-1-yl dimethyl phosphate
dimethyl (e)-2-dimethyl-carbamoyl-1-methylvinyl phosphate
dicrotophos
CHEBI:38658 ,
bidrin
3-(dimethoxyphosphinyloxy)-n,n-dimethyl-cis-crotonamide
141-66-2
(e)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate
3-dimethoxyphosphinoyloxy-n,n-dimethylisocrotonamide
brn 1880084
dimethyl 2-dimethylcarbamoyl-1-methyl-vinyl phosphate
o,o-dimethyl-o-(1,4-dimethyl-3-oxo-4-aza-pent-1-enyl)phosphate
oms 253
dimethyl ester with (e)-3-hydroxy-n,n-dimethylcrotonamide phosphoric acid
o,o-dimethyl-o-(1,4-dimethyl-3-oxo-4-aza-pent-1-enyl)fosfaat [dutch]
hsdb 1637
caswell no. 376
(e)-3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl phosphate
crotonamide, 3-hydroxy-n-n-dimethyl-, dimethyl phosphate, cis-
dimethyl 1-dimethylcarbamoyl-1-propen-2-yl phosphate
ent 24,482
ektafos
ciba 709
shell sd-3562
o,o-dimethyl-o-(1-methyl-2-n,n-dimethyl-carbamoyl)-vinyl-phosphat [german]
dimethyl phosphate of 3-hydroxy-n,n-dimethyl-cis-crotonamide
diapadrin
karbicron
phosphate de dimethyle et de 2-dimethylcarbamoyl 1-methyl vinyle [french]
oleobidrin
phosphoric acid, dimethyl 1-methyl-n,n-(dimethylamino)-3-oxo-1-propenyl ester, (e)-
sd 3562
cis-2-dimethylcarbamoyl-1-methylvinyl dimethylphosphate
(e)-3-(dimethylamino)-1-methyl-3-oxoprop-1-enyl dimethyl phosphate
3-dimethoxyphosphinyloxy-n,n-dimethylisocrotonamide
dicrotophos [bsi:iso]
epa pesticide chemical code 035201
einecs 205-494-3
phosphoric acid, dimethyl ester, ester with (e)-3-hydroxy-n,n-dimethylcrotonamide
dimethyl phosphate ester with (e)-3-hydroxy-n,n-dimethylcrotonamide
3-hydroxy-n,n-dimethyl-cis-crotonamide dimethyl phosphate
ai3-24482
3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl phosphate (e)-isomer
carbicron
carbomicron
o,o-dimetil-o-(1,4-dimetil-3-oxo-4-aza-pent-1-enil)-fosfato [italian]
dimethyl phosphate ester with 3-hydroxy-n,n-dimethyl-cis-crotonamide
o,o-dimethyl-o-(2-dimethyl-carbamoyl-1-methyl-vinyl)phosphat [german]
crotonamide, 3-hydroxy-n-n-dimethyl-, dimethyl phosphate, (e)-
c 709
3-hydroxydimethyl crotonamide dimethyl phosphate
dicrotofos [dutch]
o,o-dimethyl o-(n,n-dimethylcarbamoyl-1-methylvinyl) phosphate
2-dimethyl cis-2-dimethyl-carbamoyl-1-methylvinyl phosphate
phosphoric acid, 3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl ester, (e)-
phosphoric acid, dimethyl ester, ester with 3-hydroxy-n,n-dimethylcrotonamide, (e)-
NCGC00163830-01
NCGC00163830-02
[(e)-4-(dimethylamino)-4-oxobut-2-en-2-yl] dimethyl phosphate
NCGC00163830-03
C18656
dtxsid9023914 ,
tox21_301078
cas-141-66-2
NCGC00254979-01
dtxcid003914
3-(dimethylamino)-1-methyl-3-oxoprop-1-enyl dimethyl phosphate
dicrotofos
phosphoric acid, (1e)-3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl ester
o,o-dimethyl-o-(1-methyl-2-n,n-dimethyl-carbamoyl)-vinyl-phosphat
unii-b541i65wbl
o,o-dimethyl-o-(1,4-dimethyl-3-oxo-4-aza-pent-1-enyl)fosfaat
phosphate de dimethyle et de 2-dimethylcarbamoyl 1-methyl vinyle
b541i65wbl ,
o,o-dimetil-o-(1,4-dimetil-3-oxo-4-aza-pent-1-enil)-fosfato
o,o-dimethyl-o-(2-dimethyl-carbamoyl-1-methyl-vinyl)phosphat
AKOS015904059
sd-3562
dicrotophos [mi]
dicrotophos [iso]
ent-24482
(1e)-3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl phosphate
SCHEMBL26457
SCHEMBL3734382
CHEMBL1876467
3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl phosphate, (e)-
crotonamide, 3-hydroxy-n,n-dimethyl-, cis-, dimethyl phosphate
VEENJGZXVHKXNB-VOTSOKGWSA-N
phosphoric acid 3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl ester, (e)-
dimethyl 2-dimethylcarbamoyl-1-methylvinyl phosphate
trans-bidrin
bidirl
o,o-dimethyl-o-(2-dimethyl-carbamoyl-1-methyl-vinyl)phosphate
(1e)-3-(dimethylamino)-1-methyl-3-oxo-1-propenyl dimethyl phosphate #
W-109506
dicrotophos, pestanal(r), analytical standard
(e)-4-(dimethylamino)-4-oxobut-2-en-2-yl dimethyl phosphate
(2e)-4-(dimethylamino)-4-oxobut-2-en-2-yl dimethyl phosphate
Q411748
phosphoric acid,(1e)-3-(dimethylamino)-1-methyl-3-oxo-1-propen-1-yl dimethyl ester

Research Excerpts

Toxicity

Dicrotophos was much less toxic than the other chemicals tested. On the other hand, monocrotophos and phosphamidon were somewhat more toxic to the young rat.

ExcerptReferenceRelevance
" On the other hand, monocrotophos, dicrotophos, and phosphamidon were somewhat more toxic to the young rat, but the magnitude of the differences was < 2-fold lower."( Age-related differences in acute neurotoxicity produced by mevinphos, monocrotophos, dicrotophos, and phosphamidon.
Moser, VC,
)
0.13
" Based on the LC50s and LC75s, dicrotophos was much less toxic than the other chemicals tested."( Toxicity of Bifenthrin and Mixtures of Bifenthrin Plus Acephate, Imidacloprid, Thiamethoxam, or Dicrotophos to Adults of Tarnished Plant Bug (Hemiptera: Miridae).
Duckworth, JL; Jones, MM; Robertson, J, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
"In search of a better prophylactic compound, we determined in vivo the protection conferred by five cholinesterase inhibitors (ranitidine, physostigmine, tacrine, K-27 and pyridostigmine), which were administered in equitoxic dosage (1/4 of LD01) 30 minutes before exposure to the organophosphate dicrotophos."( Optimal Pre-treatment for Acute Exposure to the Organophosphate Dicrotophos.
Hasan, MY; Kuca, K; Lorke, DE; Nurulain, SM; Petroianu, GA, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
acaricideA substance used to destroy pests of the subclass Acari (mites and ticks).
avicideA substance used to destroy bird pests (class Aves).
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
dialkyl phosphate
organophosphate insecticide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency39.36810.002541.796015,848.9004AID1347395; AID1347397; AID1347398
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency0.00170.003041.611522,387.1992AID1159553
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00200.023723.228263.5986AID588543
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency24.32470.010039.53711,122.0200AID588545; AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency68.58960.000627.21521,122.0200AID651741
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (48.57)18.7374
1990's3 (8.57)18.2507
2000's5 (14.29)29.6817
2010's10 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (7.50%)4.05%
Observational0 (0.00%)0.25%
Other37 (92.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]